Safe Orthopaedics S.A.
ALSAF.PA · PAR
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | €2,606 | €2,901 | €2,909 | €3,116 |
| % Growth | -10.2% | -0.3% | -6.6% | – |
| Cost of Goods Sold | €2,649 | €1,487 | €0 | €4,922 |
| Gross Profit | -€43 | €1,414 | €2,909 | -€1,806 |
| % Margin | -1.7% | 48.7% | 100% | -58% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €3,538 | €227 | €0 | €1,175 |
| SG&A Expenses | €3,555 | €262 | €0 | €1,175 |
| Sales & Mktg Exp. | €17 | €35 | €0 | €0 |
| Other Operating Expenses | -€1,552 | €12,039 | €0 | -€285 |
| Operating Expenses | €2,003 | €12,301 | €0 | €890 |
| Operating Income | -€2,046 | -€10,887 | €2,909 | -€2,696 |
| % Margin | -78.5% | -375.3% | 100% | -86.5% |
| Other Income/Exp. Net | -€139,855 | -€263,338 | €0 | -€368 |
| Pre-Tax Income | -€141,901 | -€271,316 | €0 | -€3,064 |
| Tax Expense | €17,854 | -€65,872 | €0 | €2 |
| Net Income | -€159,755 | -€205,444 | -€102,722 | -€3,064 |
| % Margin | -6,130.3% | -7,081.8% | -3,531.2% | -98.3% |
| EPS | -1,791,387 | -2,706,764 | 0 | -42,300 |
| % Growth | 33.8% | – | 100% | – |
| EPS Diluted | -1,585,390 | -2,348,260 | 0 | -25,063 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | -€263,498 | €0 | -€152 |
| Interest Expense | €211,447 | €218 | €0 | -€56 |
| Depreciation & Amortization | -€37 | €2,753 | €122 | €587 |
| EBITDA | €69,509 | -€271,080 | €2,909 | -€2,477 |
| % Margin | 2,667.3% | -9,344.4% | 100% | -79.5% |